BioCardia Inc. Common Stock (BCDA)

About BCDA

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Website

www.biocardia.com/

Fundamentals

Market cap

$10.80M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.80

Dividend yield

—

Beta

0.61

Avg. volume

—

BioCardia Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• BCDA

  BioCardia Inc. Common Stock

  $1.16

  ▼ 0.85%
  Market cap $10.80MP/E —
  $0.75$2.29
• INTS

  Intensity Therapeutics Inc. Common stock

  $4.25

  ▲ 0.95%
  Market cap $11.49MP/E —
  $3.51$43.5
• CRIS

  Curis Inc. Common Stock

  $1.49

  ▲ 2.76%
  Market cap $8.59MP/E —
  $1.4$39
• AIM

  AIM ImmunoTech Inc. Common Stock

  $0.2558

  ▲ 2.32%
  Market cap $7.51MP/E —
  $0.1901$2.89
• PASG

  Passage Bio Inc. Common Stock

  $4.52

  ▲ 4.39%
  Market cap $14.11MP/E —
  $3.29$20
• VIVS

  VivoSim Labs Inc. Common Stock

  $0.29

  ▲ 0.00%
  Market cap $5.53MP/E —
  $0.2625$5.3
• BCAB

  BioAtla Inc. Common Stock

  $1.79

  ▼ 42.99%
  Market cap $5.53MP/E —
  $2.81$71.5

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• BioCardia Says FDA Finalized Pre-Submission Meeting Minutes For Helix Transendocardial Delivery Catheter; Plans Follow-On Pre-Submission This Quarter Toward Potential De Novo Approval
  benzinga · 8/24/2026
• BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulatory Wins in Japan and US ...
  Yahoo · 8/13/2026
• BioCardia, Inc. Q2 2026 Earnings Call Summary
  Yahoo · 8/13/2026
• BioCardia, Inc. (BCDA) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/13/2026
• BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results
  Yahoo · 8/12/2026
• BioCardia Q2 EPS $(0.13) Beats $(0.18) Estimate
  Benzinga · 8/12/2026
• BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026
  Yahoo · 8/5/2026

• Altman Peter · August 13, 2026 · Buy

  1.9K @ $0.92
• Altman Peter · July 29, 2026 · Buy

  5.0K @ $0.78
• Altman Peter · July 17, 2026 · Buy

  500 @ $0.83
• Altman Peter · July 15, 2026 · Buy

  1.5K @ $0.86
• Altman Peter · July 14, 2026 · Buy

  2.8K @ $0.88
• Altman Peter · July 10, 2026 · Buy

  1.0K @ $0.94
• Altman Peter · July 9, 2026 · Buy

  1.0K @ $0.9
• Altman Peter · July 8, 2026 · Buy

  5.5K @ $0.97
• Altman Peter · July 8, 2026 · Buy

  5.4K @ $0.9645
• Facteau Bill · July 6, 2026 · Grant

  8.0K
• Marvin Slosman · July 6, 2026 · Grant

  8.0K
• Blank Andrew Scott · July 6, 2026 · Grant

  8.0K
• Allen Jim L. · July 6, 2026 · Grant

  8.0K
• McClung David · July 6, 2026 · Grant

  41.5K
• Altman Peter · July 6, 2026 · Grant

  57.7K

Institutional Ownership

March 31, 2026

Total shares held

620.0K

Total value held

$725.6K

Institutional holders

16